CN1742816A - Wujiaofeng root external-use medicine - Google Patents
Wujiaofeng root external-use medicine Download PDFInfo
- Publication number
- CN1742816A CN1742816A CN 200510106596 CN200510106596A CN1742816A CN 1742816 A CN1742816 A CN 1742816A CN 200510106596 CN200510106596 CN 200510106596 CN 200510106596 A CN200510106596 A CN 200510106596A CN 1742816 A CN1742816 A CN 1742816A
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- schefflerae arboricolae
- caulis
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The present invention discloses a Wujiaofeng root medicine for external application for effectively curing the diseases of rheumatic lumbago and scelalgia, traumatic injuries, rheumatic bone pain, rheumatic arthritis and arthralgia due to wind-cold-dampness, etc. It is made up by using 8 Chinese medicinal materials of Wujiaofeng root, sedum aizoon root, sanicula coerulescens, chuifengsan, tongoloa dunnii, stauntonia hexaphylla and others and adding ethyl alcohol through a certain preparation process.
Description
Technical field:
The present invention relates to a kind of Cortex Aceris Sinensis medicine for external use.
Background technology:
The traumatic injury disease is a kind of common disease, from ancient times to the present ill people is a lot, be subjected to ailing the torment, the various medicine for external use of Xiao Shouing are also a lot of in the market, slight illness for this quasi drugs treatment traumatic injury has played certain therapeutical effect really, but does not also have a kind of external specific drug of ideal treatment traumatic injury.
Summary of the invention:
The inventor is at above-mentioned weak point, and it is convenient to have a kind of treatment at patient's urgent needs, eutherapeutic medicine for external use; The inventor, verifies and by clinical trial repeatedly through research repeatedly, finally developed a kind of with low cost, prescription rationally, preparation is simple, very easy to use, compare with existing similar medicine for external use curative effect, better efficacy is a kind of medicine for external use of good traumatic injury.
Purpose of the present invention just provides a kind of Cortex Aceris Sinensis medicine for external use.
Choice of drug Cortex Aceris Sinensis of the present invention, Radix sedi aizoon, Herba boeae clarkeanae, Caulis Seu Radix Kadsurae Oblongifoliae, Radix Tongoloae Dunnii, Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae), Lysimachia trientaloides Hemsl., Rhizoma Polygoni Cuspidati, ethanol (concentration is 35-75%) are formed; Wherein select Cortex Aceris Sinensis for use: have eliminating stasis to stop pain; Control traumatic injury, arthralgia.Select Radix sedi aizoon for use: have the hemostasis dissipating blood stasis, subduing swelling and relieving pain; Control bones and tendons injury pain, traumatic hemorrhage.Select Herba boeae clarkeanae for use: have styptic powder blood, Repercusion analgesia; Control traumatic injury, traumatic hemorrhage.Select Caulis Seu Radix Kadsurae Oblongifoliae for use: have expelling wind and removing dampness, promoting the circulation of QI to relieve pain; Dispelling the wind and dampness pathogens pain, traumatic injury.Select Radix Tongoloae Dunnii for use: have hemostatic analgesia, promoting blood circulation to remove blood stasis, expelling wind and removing dampness; Control traumatic injury, dampen, sprain, articular muscle is ached.Select Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) for use: have promoting blood circulation and stopping pain, expelling wind and removing dampness; Control traumatic injury, rheumatic arthritis, soft tissue contusion.Select Lysimachia trientaloides Hemsl. for use: have and dispel the wind, invigorate blood circulation; The dispelling the wind and dampness pathogens arthralgia pain, hemiplegia, traumatic injury.Select Rhizoma Polygoni Cuspidati for use: have expelling wind and removing dampness, dissipating blood stasis to promote menstruationg; The dispelling the wind and dampness pathogens bones and muscles pain, traumatic injury.Make the effect of each medicine produce collaborative effect these drug regimens, thereby can realize effectively treatment sprain swell and ache, disease that rheumatic lumbago and scelalgia, traumatic injury stasis of blood pain, sprain fracture, rheumatic ostalgia, rheumatism bones and muscles pain, muscles and bones are sprained pain, traumatic injury, arthralgia, bones and tendons injury pain, traumatic hemorrhage, traumatic injury sprain and contusion wound, rheumatalgia, bones and muscles pain, soft tissue contusion, osteopatia sprain, Fengshi Guanjie pain, rheumatic arthritis, rheumatism waist leg joint pain, curative effect is illustrious.
The consumption of drug component of the present invention also is to carry out a large amount of solid lines through the inventor to grope to sum up and draw, and each amounts of components is for all to have better therapeutic effect in the following weight parts scope; It is made up of the component of following parts by weight:
Cortex Aceris Sinensis 1-10, Radix sedi aizoon 1-14 part, Herba boeae clarkeanae 1-10 part, Caulis Seu Radix Kadsurae Oblongifoliae 1-14 part, Radix Tongoloae Dunnii 1-10 part, Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) 1-8 part, Lysimachia trientaloides Hemsl. 1-8 part, Rhizoma Polygoni Cuspidati 1-14 part, ethanol (concentration is 35-75%) 32-352 part.
Optimization formula of the present invention is:
7 parts of Cortex Aceris Sinensiss, 11 parts of Radix sedi aizoons, 7 parts of Herba boeae clarkeanaes, 11 parts of Caulis Seu Radix Kadsurae Oblongifoliaes, 7 parts of Radix Tongoloae Dunnii, 5 parts of Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae)s, 5 parts of Lysimachia trientaloides Hemsl.s, 11 parts of Rhizoma Polygoni Cuspidati, 256 parts of ethanol (concentration is 35-75%).
A kind of Cortex Aceris Sinensis medicine for external use of the present invention has relaxing muscles and tendons and activating QI and blood in the collateral, promoting blood circulation to remove blood stasis, an effect of the analgesia of dispeling the wind; Be a kind of with low cost, prescription rationally, preparation is simple, easy to use, compares with existing similar medicine for external use curative effect, Cortex Aceris Sinensis medicine for external use curative effect is fine.Cortex Aceris Sinensis medicine for external use of the present invention was once done a large amount of clinical trials in early stage, give on the patient treatment case surplus in the of tens example time, comprise be used for the treatment of sprain swell and ache, disease that rheumatic lumbago and scelalgia, traumatic injury stasis of blood pain, sprain fracture, rheumatic ostalgia, rheumatism bones and muscles pain, muscles and bones are sprained pain, traumatic injury, arthralgia, bones and tendons injury pain, traumatic hemorrhage, traumatic injury sprain and contusion wound, rheumatalgia, bones and muscles pain, soft tissue contusion, osteopatia sprain, Fengshi Guanjie pain, rheumatic arthritis, rheumatism waist leg joint pain, do not see untoward reaction during the treatment.Total effective rate is more than 87%, and curative effect is illustrious.
Using method:
This medicine is a medicine for external use, and oral administration is at first cleaned the affected part with hot water, will dab in the affected part with the drenched medicinal liquid of absorbent cotton, and be good with palm of the hand stranding or the heating of tip-tap affected part, every day 3-6 time.
The specific embodiment:
Describe embodiments of the invention below in detail:
Embodiment 1:
A kind of Cortex Aceris Sinensis medicine for external use provided by the present invention is made up of the component of following parts by weight; Cortex Aceris Sinensis 1-10, Radix sedi aizoon 1-14 part, Herba boeae clarkeanae 1-10 part, Caulis Seu Radix Kadsurae Oblongifoliae 1-14 part, Radix Tongoloae Dunnii 1-10 part, Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) 1-8 part, Lysimachia trientaloides Hemsl. 1-8 part, Rhizoma Polygoni Cuspidati 1-14 part, ethanol (concentration is 35-75%) 32-352 part.
Embodiment 2:
Optimization formula of the present invention is:
7 parts of Cortex Aceris Sinensiss, 11 parts of Radix sedi aizoons, 7 parts of Herba boeae clarkeanaes, 11 parts of Caulis Seu Radix Kadsurae Oblongifoliaes, 7 parts of Radix Tongoloae Dunnii, 5 parts of Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae)s, 5 parts of Lysimachia trientaloides Hemsl.s, 11 parts of Rhizoma Polygoni Cuspidati, 256 parts of ethanol (concentration is 35-75%).
Preparation method of the present invention is: at first with above-mentioned Cortex Aceris Sinensis, Radix sedi aizoon, Herba boeae clarkeanae, Caulis Seu Radix Kadsurae Oblongifoliae, Radix Tongoloae Dunnii, Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae), Lysimachia trientaloides Hemsl., Rhizoma Polygoni Cuspidati, the single short fragment that is cut into respectively, each single short fragment that is cut into is mixed in proportion together, be placed in the container then, and allocate ethanol (concentration is 35-75%) into, stir the back sealed container in, according to the modern Chinese medicine processing technology or after soaking 10-15 days, the mixture solution after handling packed into by the required metering of client to get product in the bottle.
Claims (3)
1, a kind of Cortex Aceris Sinensis medicine for external use is characterized in that: Cortex Aceris Sinensis, Radix sedi aizoon, Herba boeae clarkeanae, Caulis Seu Radix Kadsurae Oblongifoliae, Radix Tongoloae Dunnii, Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae), Lysimachia trientaloides Hemsl., Rhizoma Polygoni Cuspidati, ethanol (concentration is 35-75%).
2, a kind of Cortex Aceris Sinensis medicine for external use according to claim 1, it is characterized in that: the component by following parts by weight is formed; Cortex Aceris Sinensis 1-10, Radix sedi aizoon 1-14 part, Herba boeae clarkeanae 1-10 part, Caulis Seu Radix Kadsurae Oblongifoliae 1-14 part, Radix Tongoloae Dunnii 1-10 part, Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) 1-8 part, Lysimachia trientaloides Hemsl. 1-8 part, Rhizoma Polygoni Cuspidati 1-14 part, ethanol 32-352 part.
3, a kind of Cortex Aceris Sinensis medicine for external use according to claim 1, it is characterized in that: the component by following parts by weight is formed; 7 parts of Cortex Aceris Sinensiss, 11 parts of Radix sedi aizoons, 7 parts of Herba boeae clarkeanaes, 11 parts of Caulis Seu Radix Kadsurae Oblongifoliaes, 7 parts of Radix Tongoloae Dunnii, 5 parts of Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae)s, 5 parts of Lysimachia trientaloides Hemsl.s, 11 parts of Rhizoma Polygoni Cuspidati, 256 parts of ethanol.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510106596 CN1742816A (en) | 2005-10-07 | 2005-10-07 | Wujiaofeng root external-use medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510106596 CN1742816A (en) | 2005-10-07 | 2005-10-07 | Wujiaofeng root external-use medicine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1742816A true CN1742816A (en) | 2006-03-08 |
Family
ID=36138441
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200510106596 Pending CN1742816A (en) | 2005-10-07 | 2005-10-07 | Wujiaofeng root external-use medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1742816A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102204994A (en) * | 2011-05-19 | 2011-10-05 | 胡青竹 | Chinese medicinal preparation for treating osteoarthritis and preparation method thereof |
| CN103405649A (en) * | 2013-08-19 | 2013-11-27 | 刘建贞 | External pharmaceutical composition for recovery after nervus peroneus communis injury |
| CN103826651A (en) * | 2011-08-18 | 2014-05-28 | 财团法人全南生物产业振兴院 | Medical composition containing stauntonia hexaphylla extract |
-
2005
- 2005-10-07 CN CN 200510106596 patent/CN1742816A/en active Pending
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102204994A (en) * | 2011-05-19 | 2011-10-05 | 胡青竹 | Chinese medicinal preparation for treating osteoarthritis and preparation method thereof |
| CN102204994B (en) * | 2011-05-19 | 2012-11-28 | 胡青竹 | Chinese medicinal preparation for treating osteoarthritis and preparation method thereof |
| CN103826651A (en) * | 2011-08-18 | 2014-05-28 | 财团法人全南生物产业振兴院 | Medical composition containing stauntonia hexaphylla extract |
| EP2774617A4 (en) * | 2011-08-18 | 2015-02-18 | Jeonnam Bioindustry Foundation | Medical composition containing stauntonia hexaphylla extract |
| US9370542B2 (en) | 2011-08-18 | 2016-06-21 | Jeonnam Bioindustry Foundation | Medical composition containing Stauntonia hexaphylla extract |
| EP3097920A1 (en) * | 2011-08-18 | 2016-11-30 | Jeonnam Bioindustry Foundation | Medical composition comprising stauntonia hexaphylla extract |
| CN103405649A (en) * | 2013-08-19 | 2013-11-27 | 刘建贞 | External pharmaceutical composition for recovery after nervus peroneus communis injury |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1742895A (en) | External-use medicine of Herba sarcandrae | |
| CN1742816A (en) | Wujiaofeng root external-use medicine | |
| CN1814010A (en) | Japanese supplejack collateral-flow-activating pain-relieving medicine | |
| CN1813944A (en) | External-use drug of securidaca inappendiculata hassk for traumatic injury and activating collaterals | |
| CN1814134A (en) | Collateral-flow-activating external-use medicine of Radix Seu Folium Clematidis Henryi for treating injuries by falls | |
| CN1813952A (en) | Medicine of yellow cinnamon root for activating collaterals | |
| CN1742801A (en) | Qianjinba external-use medicine | |
| CN1813898A (en) | External-use medicine of hayberry bark for traumatic injury and activating collaterals | |
| CN1762469A (en) | Externally applied medicine of madeira vine | |
| CN1814066A (en) | Collateral-flow-activating pain-relieving medicine of caulis et Folium Trachelospermi | |
| CN1814203A (en) | Collateral-flow-activating external-use medicine of Herba et Radix Inebriantis for treating injuries by falls | |
| CN1814065A (en) | Collateral-flow-activating pain-relieving medicine of Herba Tetrastigmae Yunnanensis | |
| CN1739693A (en) | Externally applied medicine of dunn tongoloa root | |
| CN1742815A (en) | External-use medicine of lysimachia root | |
| CN1742857A (en) | Berchemia sinica schneid external-use medicine | |
| CN1742839A (en) | Nutritious health-care oral liquor for woman and preparing process | |
| CN1742907A (en) | External-use medicine of Radix celastri orbiculati | |
| CN1762479A (en) | Externally applied medicine of stahlianthus involucratus | |
| CN1814103A (en) | Collateral-flow-activating pain-relieving medicine of Radix Ardisiae crenatae | |
| CN1762436A (en) | Externally applied medicine of Ligularia lapathifolia | |
| CN1742972A (en) | External-use medicine of Herba chloranthi multistachydis | |
| CN1742961A (en) | External-use medicine of Rhizome cyperi | |
| CN1814088A (en) | Wind-repellent collateral-activating pain-relieving medicine of Radix Rhodiolae | |
| CN1814087A (en) | Wind-repellent collateral-activating pain-relieving medicine of Herba clemati dis Intricatae | |
| CN1813930A (en) | Chinese medicine of securidaca inappendiculata hassk for activating collaterals and stopping pain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |